165 related articles for article (PubMed ID: 8552111)
1. Neurological Wilson's disease studied with magnetic resonance imaging and with positron emission tomography using dopaminergic markers.
Westermark K; Tedroff J; Thuomas KA; Hartvig P; Långström B; Andersson Y; Hörnfeldt K; Aquilonius SM
Mov Disord; 1995 Sep; 10(5):596-603. PubMed ID: 8552111
[TBL] [Abstract][Full Text] [Related]
2. Striatal D2 receptor status in patients with Parkinson's disease, striatonigral degeneration, and progressive supranuclear palsy, measured with 11C-raclopride and positron emission tomography.
Brooks DJ; Ibanez V; Sawle GV; Playford ED; Quinn N; Mathias CJ; Lees AJ; Marsden CD; Bannister R; Frackowiak RS
Ann Neurol; 1992 Feb; 31(2):184-92. PubMed ID: 1575457
[TBL] [Abstract][Full Text] [Related]
3. Levodopa-induced changes in synaptic dopamine in patients with Parkinson's disease as measured by [11C]raclopride displacement and PET.
Tedroff J; Pedersen M; Aquilonius SM; Hartvig P; Jacobsson G; Långström B
Neurology; 1996 May; 46(5):1430-6. PubMed ID: 8628494
[TBL] [Abstract][Full Text] [Related]
4. Treatment with D-penicillamine improves dopamine D2-receptor binding and T2-signal intensity in de novo Wilson's disease.
Schwarz J; Antonini A; Kraft E; Tatsch K; Vogl T; Kirsch CM; Leenders KL; Oertel WH
Neurology; 1994 Jun; 44(6):1079-82. PubMed ID: 8208404
[TBL] [Abstract][Full Text] [Related]
5. Relationship between striatal glucose consumption and copper excretion in patients with Wilson's disease treated with D-penicillamine.
Hefter H; Kuwert T; Herzog H; Arendt G; Stremmel W; Feinendegen LE
J Neurol; 1993 Nov; 241(1):49-53. PubMed ID: 8138822
[TBL] [Abstract][Full Text] [Related]
6. The nigrostriatal dopaminergic pathway in Wilson's disease studied with positron emission tomography.
Snow BJ; Bhatt M; Martin WR; Li D; Calne DB
J Neurol Neurosurg Psychiatry; 1991 Jan; 54(1):12-7. PubMed ID: 1901347
[TBL] [Abstract][Full Text] [Related]
7. Presynaptic and postsynaptic striatal dopaminergic function in patients with manganese intoxication: a positron emission tomography study.
Shinotoh H; Snow BJ; Chu NS; Huang CC; Lu CS; Lee C; Takahashi H; Calne DB
Neurology; 1997 Apr; 48(4):1053-6. PubMed ID: 9109899
[TBL] [Abstract][Full Text] [Related]
8. D2 receptor binding in dopa-responsive dystonia.
Künig G; Leenders KL; Antonini A; Vontobel P; Weindl A; Meinck HM
Ann Neurol; 1998 Nov; 44(5):758-62. PubMed ID: 9818931
[TBL] [Abstract][Full Text] [Related]
9. Extrapyramidal symptoms in Wilson's disease are associated with olfactory dysfunction.
Mueller A; Reuner U; Landis B; Kitzler H; Reichmann H; Hummel T
Mov Disord; 2006 Sep; 21(9):1311-6. PubMed ID: 16763975
[TBL] [Abstract][Full Text] [Related]
10. [Clinico-radiological correlation of Wilson's disease by magnetic resonance imaging, computed and positron emission tomography].
Ikeda K; Sakata C; Nemoto H; Yokoi F; Sunohara N; Iio M
Rinsho Shinkeigaku; 1991 Feb; 31(2):147-53. PubMed ID: 2060237
[TBL] [Abstract][Full Text] [Related]
11. Manganese induced brain lesions in Macaca fascicularis as revealed by positron emission tomography and magnetic resonance imaging.
Eriksson H; Tedroff J; Thuomas KA; Aquilonius SM; Hartvig P; Fasth KJ; Bjurling P; Långström B; Hedström KG; Heilbronn E
Arch Toxicol; 1992; 66(6):403-7. PubMed ID: 1444804
[TBL] [Abstract][Full Text] [Related]
12. Presynaptic and postsynaptic striatal dopaminergic function in neuroacanthocytosis: a positron emission tomographic study.
Brooks DJ; Ibanez V; Playford ED; Sawle GV; Leigh PN; Kocen RS; Harding AE; Marsden CD
Ann Neurol; 1991 Aug; 30(2):166-71. PubMed ID: 1897909
[TBL] [Abstract][Full Text] [Related]
13. Pretreatment and posttreatment positron emission tomographic scan imaging in a 20-year-old patient with Wilson's disease.
Cordato DJ; Fulham MJ; Yiannikas C
Mov Disord; 1998 Jan; 13(1):162-6. PubMed ID: 9452344
[TBL] [Abstract][Full Text] [Related]
14. Striatal dopaminergic function in restless legs syndrome: 18F-dopa and 11C-raclopride PET studies.
Turjanski N; Lees AJ; Brooks DJ
Neurology; 1999 Mar; 52(5):932-7. PubMed ID: 10102408
[TBL] [Abstract][Full Text] [Related]
15. Correlation between automated writing movements and striatal dopaminergic innervation in patients with Wilson's disease.
Hermann W; Eggers B; Barthel H; Clark D; Villmann T; Hesse S; Grahmann F; Kühn HJ; Sabri O; Wagner A
J Neurol; 2002 Aug; 249(8):1082-7. PubMed ID: 12195459
[TBL] [Abstract][Full Text] [Related]
16. Fluorodopa and raclopride PET analysis of patients with Machado-Joseph disease.
Shinotoh H; Thiessen B; Snow BJ; Hashimoto S; MacLeod P; Silveira I; Rouleau GA; Schulzer M; Calne DB
Neurology; 1997 Oct; 49(4):1133-6. PubMed ID: 9339702
[TBL] [Abstract][Full Text] [Related]
17. A two-compartment description and kinetic procedure for measuring regional cerebral [11C]nomifensine uptake using positron emission tomography.
Salmon E; Brooks DJ; Leenders KL; Turton DR; Hume SP; Cremer JE; Jones T; Frackowiak RS
J Cereb Blood Flow Metab; 1990 May; 10(3):307-16. PubMed ID: 2329119
[TBL] [Abstract][Full Text] [Related]
18. [The onset of psychiatric disorders and Wilson's disease].
Benhamla T; Tirouche YD; Abaoub-Germain A; Theodore F
Encephale; 2007 Dec; 33(6):924-32. PubMed ID: 18789784
[TBL] [Abstract][Full Text] [Related]
19. Psychiatric symptoms as late onset of Wilson's disease: neuroradiological findings, clinical features and treatment.
Keller R; Torta R; Lagget M; Crasto S; Bergamasco B
Ital J Neurol Sci; 1999 Feb; 20(1):49-54. PubMed ID: 10933485
[TBL] [Abstract][Full Text] [Related]
20. Morphological and functional imaging in neurological and non-neurological Wilson's patients.
Hermann W
Ann N Y Acad Sci; 2014 May; 1315():24-9. PubMed ID: 24495036
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
